Document is current
Any future updates will be listed below
-
Authors
Smid, Marcel
Schmidt, Marjanka K.
Prager-van der Smissen, Wendy J. C.
Ruigrok-Ritstier, Kirsten
Schreurs, Maartje A. C.
Cornelissen, Sten
Garcia, Aida Marsal
Broeks, Annegien
Timmermans, A. Mieke
Trapman-Jansen, Anita M. A. C.
Collée, J. Margriet
Adank, Muriel A.
Hooning, Maartje J.
Martens, John W. M.
Hollestelle, Antoinette
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (KWF 10758/2016-2)
- License Information
-
More Information
Article History
Received: 13 March 2023
Accepted: 2 May 2023
First Online: 9 May 2023
Declarations
:
: This study was approved by the Medical Ethical Committees of the Erasmus University Medical Centre (MEC 02.953 and MEC 11.226) and the Netherlands Cancer Institute (CFMPB652). All retrospective medical data and/or biospecimen studies at both institutes have been executed pursuant to Dutch legislation and international standards. Prior to 25 May 2018, national legislation on data protection applied, as well as the International Guideline on Good Clinical Practice. From 25 May 2018, we also adhere to the GDPR. Within this framework, patients are informed and have always had the opportunity to object or actively consent to the (continued) use of their personal data and biospecimens in research. Hence, the procedures comply both with (inter-)national legislative and ethical standards.
: Not applicable.
: The authors declare no potential competing interests.
